Company intelligence / Profile preview

Keit

Abingdon, England, United Kingdomkeit.al ↗

Ownership: Private
Development stage: Other

Overview

Keit's IRmadillo spectrometer enables real-time, in situ monitoring of industrial processes such as fermentation, cell culture, biofuel production, enzyme manufacturing, and chemical processing. It improves efficiency by providing immediate feedback on process conditions without the need for off-line sample analysis[1][3]. The instrument is robust enough to withstand harsh cleaning protocols common in bioprocessing environments.

Modalities: Process analytical technology (PAT)
Industry: Drug Discovery Services

Partnerships

Centre for Process Analytics and Control Technology (CPACT)Royal Society of Chemistry (EnterprisePlus Member)IBioIC Industry Member

Beyond the preview

Go deeper on Keit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keit.

Explore the full profile